Cedars-Sinai Selected as Regional Treatment Center for Ebola and Other Infectious Diseases
Cedars-Sinai will play a critical role in bolstering the nation’s front-line defense against Ebola and other highly infectious diseases under a federal grant meant to improve the response to emerging medical threats.
The U.S. Department of Health and Human Services has tapped Cedars-Sinai to serve as a regional treatment center for patients with severe infectious diseases. The medical center and the California Department of Public Health will share a $3.25-million grant from the federal agency through fiscal year 2019 to strengthen the delivery of specialized emergency medical care.
Cedars-Sinai and the state health agency will become part of a national network of 10 regional treatment centers. The hospital will be responsible for patients from California, Arizona, Nevada, Hawaii and U.S. territories in the Pacific.
“We are honored to take on this important leadership role in the nation’s healthcare system,” said Thomas M. Priselac, Cedars-Sinai’s president and CEO. “Doing so is consistent with our mission and commitment to the community and beyond in light of our role as a national leader providing the most advanced treatments to acutely ill patients with complex medical conditions from California and across America.”
As a regional treatment center, Cedars-Sinai has agreed to receive patients with severe infectious diseases within eight hours of notification; maintain infectious disease isolation capacity or negative-pressure rooms that prevent the spread of microorganisms; treat up to two Ebola patients concurrently; and accept patients from outside its region or those medically evacuated to the U.S. from overseas.
Cedars-Sinai will use the grant primarily to fund ongoing training of its Ebola Response Team and to purchase medical equipment as well as personal protective gear. In addition, the medical center is expected to conduct quarterly staff trainings and preparedness drills during the grant period.
The federal grant is part of $339.5 million in emergency funding appropriated by Congress in 2014 to ensure that the nation’s healthcare system is prepared to treat future patients with Ebola or other highly infectious pathogens.
“Ensuring the safety of all Cedars-Sinai patients, visitors and staff is our top priority,” said Rekha Murthy, MD, medical director of Hospital Epidemiology and professor of medicine in the Division of Infectious Diseases at Cedars-Sinai. “Members of our Ebola Response Team will employ the most effective protocols and the best practices available to care for all of our patients and to maximize safety when dealing with infectious diseases.”
Source: Cedars-Sinai
Newsletter
Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.
Reducing Hidden Risks: Why Sharps Injuries Still Go Unreported
July 18th 2025Despite being a well-known occupational hazard, sharps injuries continue to occur in health care facilities and are often underreported, underestimated, and inadequately addressed. A recent interview with sharps safety advocate Amanda Heitman, BSN, RN, CNOR, a perioperative educational consultant, reveals why change is overdue and what new tools and guidance can help.
New Study Explores Oral Vancomycin to Prevent C difficile Recurrence, But Questions Remain
July 17th 2025A new clinical trial explores the use of low-dose oral vancomycin to prevent Clostridioides difficile recurrence in high-risk patients taking antibiotics. While the data suggest a possible benefit, the findings stop short of statistical significance and raise red flags about vancomycin-resistant Enterococcus (VRE), underscoring the delicate balance between prevention and antimicrobial stewardship.
What Lies Beneath: Why Borescopes Are Essential for Verifying Surgical Instrument Cleanliness
July 16th 2025Despite their smooth, polished exteriors, surgical instruments often harbor dangerous contaminants deep inside their lumens. At the HSPA25 and APIC25 conferences, Cori L. Ofstead, MSPH, and her colleagues revealed why borescopes are an indispensable tool for sterile processing teams, offering the only reliable way to verify internal cleanliness and improve sterile processing effectiveness to prevent patient harm.
The Next Frontier in Infection Control: AI-Driven Operating Rooms
Published: July 15th 2025 | Updated: July 15th 2025Discover how AI-powered sensors, smart surveillance, and advanced analytics are revolutionizing infection prevention in the OR. Herman DeBoard, PhD, discusses how these technologies safeguard sterile fields, reduce SSIs, and help hospitals balance operational efficiency with patient safety.
Targeting Uncertainty: Why Pregnancy May Be the Best Time to Build Vaccine Confidence
July 15th 2025New national survey data reveal high uncertainty among pregnant individuals—especially first-time parents—about vaccinating their future children, underscoring the value of proactive engagement to strengthen infection prevention.
